Home > Press > NaturalNano Ramps up Worldwide Exploration of Additional Halloysite Nanotube (HNT™) Deposits
Company Expands Sourcing to Support Pleximer™ Suite Launch
NaturalNano Ramps up Worldwide Exploration of Additional Halloysite Nanotube (HNT™) Deposits
ROCHESTER, NY | Posted on November 19th, 2007
NaturalNano, Inc. (OTCBB: NNAN) (FWB: N3N), a developer of advanced nanomaterials and additive technologies, today announced it is ramping up current efforts aimed at developing additional domestic and international sources of halloysite nanotubes (HNT™), the key component in the Company's newly launched additive for manufacturing stronger, lighter and less expensive materials: Pleximer™.
Rochester, NY-based NaturalNano ( http://www.naturalnano.com ) said HNT occurs naturally in certain clay found in the United States, Australia, Europe, South America, and Asia, and has been mined for centuries for use in porcelain and other materials. With NaturalNano's proprietary application of HNT in its Pleximer product, manufacturers gain numerous competitive advantages over traditional additives, including the ability to create extended release applications. While the Company's current sources of HNT are fully sufficient to support current customer demand for Pleximer, NaturalNano said it launched the new exploration project to support anticipated growth and continued testing.
"The true beauty of halloysite nanotubes, beyond the clear advantage of stronger, lighter, and less expensive nanomaterials when produced with HNT , is that it can be sourced from multiple mines around the world, which will allow us to better manage costs and quality," said Cathy Fleischer, President and Chief Technical Officer of NaturalNano. "In addition, HNT's unique qualities give us the chance to fully explore the potential in our extensive IP portfolio, which we have bolstered with our exclusive license agreement with the U.S. Naval Research Laboratory."
NaturalNano said it is currently developing HNT sources and potential partnerships in the western United States as part of the Company's ongoing focus on industry partnerships and joint venture sourcing and technology development. While undergoing the development process, NaturalNano said it continues to have access to reserves of HNT to meet customer demand and to continue laboratory-scale testing of additional Pleximer products. NaturalNano has purchased and is warehousing a six month supply of HNT based on current projections, and will continue to add to the supply throughout 2008. NaturalNano said it expects to introduce several new Pleximer products in the first half of 2008, with extended release applications coming online later next year.
Fleischer concluded: "As the marketplace increasingly looks to utilize the advantages of nanocomposites in various products, our supply chain partnerships - both our joint development agreements and potential partnerships with halloysite-producing mines - place us in the lead to leverage and optimize interest in the space. As we continue to focus on HNT development, these channel partnerships, along with our tremendous technical team and focus on product commercialization, will be strong competitive advantages for us as we bring additional products to market."
About NaturalNano, Inc.
NaturalNano, Inc. (OTCBB: NNAN) (FWB: N3N) is a materials science company focused on developing and commercializing advanced nanocomposites. Based in Rochester, NY, the Company is focused on additive technologies and processes, including its proprietary Pleximer™ polymer additive, that add value to industrial polymers, plastics and composites, as well as consumer and industrial products. NaturalNano holds and licenses over 25 patents and applications, as well as proprietary know-how for extraction and separation processes, compositions, and derivatives of Halloysite and other nanotubes. For more information, visit http://www.naturalnano.com
Cautionary Statement Regarding Forward-Looking Statements: This press release may contain forward-looking statements regarding future events and future performance of NaturalNano that involve risks and uncertainties that could materially affect actual results. This information is qualified in its entirety by cautionary statements and risk factors disclosure contained in certain of NaturalNano's filings with the Securities and Exchange Commission. The most recent annual reports on Form 10-KSB and quarterly reports on Form 10-QSB filed by NaturalNano provide information about these factors, which may be revised or supplemented in future reports to the SEC on those forms or on Form 8-K. We caution investors not to place undue reliance on forward-looking statements, and we do not undertake any obligation to update or otherwise revise any forward-looking statements, whether as a result of new information, future events, or other such factors that affect the subject of these statements, except where expressly required by law.
For more information, please click here
Jeff Lambert, Patrick Kane
Lambert, Edwards & Associates
Copyright © NaturalNano, Inc.
If you have a comment, please Contact
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Wrapping carbon nanotubes in polymers enhances their performance: Scientists at Japan's Kyushu University say polymer-wrapped carbon nanotubes hold much promise in biotechnology and energy applications March 30th, 2015
DFG to Establish One Clinical Research Unit and Five Research Units: New Projects to Investigate Complications in Pregnancy, Particle Physics, Nanoparticles, Implants and Transport Planning / Approximately 13 Million Euros in Funding for an Initial Three-Year Period March 28th, 2015
Chemists make new silicon-based nanomaterials March 27th, 2015
UT Dallas engineers twist nanofibers to create structures tougher than bulletproof vests March 27th, 2015
Light-powered gyroscope is world's smallest: Promises a powerful spin on navigation April 1st, 2015
Prototype 'nanoneedles' generate new blood vessels in mice: Scientists have developed tiny 'nanoneedles' that have successfully prompted parts of the body to generate new blood vessels, in a trial in mice March 31st, 2015
Super sensitive measurement of magnetic fields March 31st, 2015
Nanomedicine pioneer Mauro Ferrari at ETH Zurich March 31st, 2015